secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2024-11-26T23:59:59+00:00
Accession:  0001005286-24-000169
Event type: debt
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore extends BMO revolving credit facility to Nov 2027, lowers rates
------------------------------------------------------------------------

- Maturity extended three years to November 2027 under BMO ABL facility.
- Interest rates simplified and reduced; no fees paid for amendments.
- Alcon term loan covenants aligned with BMO facility via separate amendment.
- Follows $24.3M PIPE financing; company says balance sheet strengthened.
- CEO cites BMO confidence and recent customer wins including Lindy Biosciences.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000169/0001005286-24-000169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000169/lndc-20241126.htm
  HTML page:      https://secwatch.observer/filing/0001005286-24-000169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer